DAFTAR PUSTAKA

1. Rasjidi I. Epidemiologi Kanker Serviks . Indonesian Journal of Cancer.2009. Vol. III, No.3 2. Daniel Tena Gmez, AND Juana Lpez Santos.HUMAN CANCER: PAPILLOMAVIRUS AND

INFECTION

CERVICAL

PATHOGENESIS

EPIDEMIOLOGY. Communicating Current Research and Educational Topics and Trends in Applied Microbiology A. Mndez-ilas(Ed) 2007. 3. Hera Noviana. Human Papillomavirus dan Kanker Serviks. Kalbe Genomics Laboratory. CDK-189/ vol. 39 no. 1, th. 2012 4. Sinta Sasika Novel, Ratu Safi Tri,Sukma Nuswantara. Human Papillomavirus (HPV). Fakultas Matematika dan Ilmu Pengetahuan Alam Universitas Padjadjaran, Bandung, Indonesia. 2012. CDK-193/ vol. 39 no. 5. 5. Ervin Adam, MD, Zuzana Berkova, PhD,a Zuzana Daxnerova, PhD,a Joseph Icenogle, PhD,c.William. Reeves, MD and Raymond H. Kaufman, MD. Papillomavirus detection: Demographic and behavioral characteristics influencing the identification of cervical disease. American Journal of Obstetrics and Gynecology. FEBRUARY 2000; volume 182 number 2 6. Eileen M. Burd. Human Papillomavirus and Cervical Cancer. Clin Microbiol Rev. 2003 January; 16(1): 117. doi: 10.1128/CMR.16.1.1-17. 7. Britt K. Erickson, MD; Ronald D. Alvarez; Warner K. Huh GENERAL GYNECOLOGY, Human papillomavirus: what every provider should know. www.AJOG.com.2012 8. Munoz, N, Bosch,FX, de Sanjose,Shah,et all,2003. Epidemiologic classification of human papillomavirus types associated with cervical cancer, New England fournal of medicine no, pp 518-527 9. Andrijono. Kanker Serviks. Divisi Onkologi Departemen Obstetri dan Ginekologi. FKUI.2012 10. Khan, MJ.Castle,PE, Lorincz,AT, Wacholder, S, Sherman, M, Scottt,DR, et al, 2005. The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utilityof type specific HPV testing in clinical practice.Journal of the National Cancer Institute, vol 97, no.14.

11. Meshkat, Z., Hassan, Z.M., Soleimanjahi, H., Mahmoodi, H., Mirshahabi , H., Farhadi Langeroudi, M. Detection of human papillomaviruses type 16 and 18 by PCR and RFLP in paraffin-embedded cervical cancer tissue specimens Archives of Razi Institute, Vol. 61, No. 3, Autumn (2006) 159-165 12. Wilyman J. The pathogenesis of Human Papillomavirus (HPV) in the development of cervical cancer: are HPV vaccines a safe and effective management strategy? The Health Hazards of Disease Prevention. BSEM March 2011. 13. Depkes RI. www.depkes.go.id/index.php/berita/press-release/873-vaksin HPV untuk perangi Kanker Serviks. Diakses tanggal 18 Mei 2013. 14. FT Cutts, S Franceschi, S Goldie, X Castellsague, S de Sanjose,G Garnet, WJ Edmund,P Claeys, KL Goldenthal, DM Harper, L Markowitz. Human Papillomavirus and HPV Vaccines : a review. Bulletin of the World Health Organization. 2010. 15. Dwipoyono B. Kebijakan Pengendalian Penyakit Kanker Serviks di Indonesia. RS Kanker Dharmais. 2009. Indonesian Journal of Cancer vol III, No.3. 16. Michelle S. Longworth and Laimonis A. Laimins .Pathogenesis of Human Papillomaviruses in Differentiating Epithelia. Microbiol. Mol. Biol. Rev. 2004, 68(2):362. DOI: 10.1128/MMBR.68.2.362-372.2004. 17. Oscar Gee-Wan Wong, C.K. Lo, Joanne N.K. Chow, Obe K.L. Tsun, Elaine Szeto, Stephanie S. Liu, Hextan Y.S. Ngan, Annie N.Y. Cheung1. Comparison of GenoFlow HPV test and Linear Array in an Asian Screening Population. 2012.J. Clin. Microbiol. doi:10.1128/JCM.05933-11 18. Manola Comar, Michelle Iannacone, Giorgia Casalicchio , Sandrine McKay-Chopin, Massimo Tommasino, Tarik Gheit. Comparison of Hybrid Capture 2, Linear 1 Array and a bead-based multiplex genotyping assay for the detection of Human Papillomavirus in negative Pap tests and Atypical Squamous Cells of Undetermined Significance. 2012.J. Clin. Microbiol. oi:10.1128/JCM.02105-12 19. WHO. World Cancer Factsheet. www.cancerresearchuk.com.2012.Diakses tanggal 5 Juni 2013 20. IARC.Globocan. 2008. www.globocan.iarc/datasource_and_methods.asp.Diakses tanggal 05 Juni 2013 21. Kjaer SK, Chackerian B, van den Brule AJ, et al. High-risk human papillomavirus is sexually transmitted: evidence from a follow-up study of virgins starting sexual activity (intercourse). Cancer Epidemiol Biomarkers Prev 2001;10: 101-6

22. Burchell AN, Tellier PP, Hanley J, Coutlee F, Franco EL. Human papillomavirus infections among couples in new sexual relationships. Epidemiology 2010;21:31-7. 23. C.L. Peyton, P.E. Gravitt, W.C. Hunt, R.S. Hundley, M. Zhao, R.J. Apple, et al. Journal of Infectious Diseases 183, 1554 (2001). 24. E. Adam, Z. Berkova, Z. Daxnerova, J. Icenogle, W.C. Reeves and R.H. Kaufman. American Journal of Obstetrics and Gynecology 182, 257 (2000). 25. Baker, T. S., W. W. Newcomb, N. H. Olson, L. M. Cowsert, C. Olson, and J. C. Brown. 1991. Structures of bovine and human papillomaviruses. Analysisby cryoelectron microscopy and three-dimensional image reconstruction.Biophys. J. 60:14451456 26. Sapp, M., C. Volpers, M. Muller, and R. E. Streck. 1995. Organization of the major and minor capsid proteins in human papillomavirus type 33 virus-like particles. J. Gen. Virol. 76:24072412. 27. Karl Mnger, Amy Baldwin, Kirsten M. Edwards, Hiroyuki Grace and KyungWon Huh Hayakawa, Christine L. Nguyen, Michael Owens, Miranda J. Mechanisms of Human Papillomavirus-Induced Oncogenesis. Virol. 2004, 78(21):11451. DOI. 10.1128/JVI.78.21.11451-11460.2004. 28. Adam, E., Z. Berkova, Z. Daxnerova, J. Icenogle, W. C. Reeves, and R. H.Kaufman. 2000. Papillomavirus detection: demographic and behavioral characteristics influencing the identification of cervical disease. Am. J. Obstet. Gynecol. 182:257 264 29. Virus Taxonomy: Eighth Report of the International Committee on Taxonomy of Viruses Claude .M. Fauquet, M.A. Mayo, J. Maniloff, U. Desselberger, and L.A. Ball (Eds) Academic Press, 1162 pp. ; 2nd edition (June 28, 2005) - ISBN: 0122499514 30. Bouvard V, Baan R, Straif K, et al. A review of human carcinogenspart B: biological agents. Lancet Oncol 2009;10:321-2. 31. Torrisi, A., A. Del Mistro, G. L. Onnis, F. Merlin, R. Bertorelle, and D. Minucci. 2000. Colposcopy, cytology and HPV testing in HIV-positive and HIV-negative women. Eur. J. Gynecol. Oncol. 21:168172. 32. A.M. Anderson. Clinical Microbiology Newsletter 24, 113 (2002) 33. Thomas M, Pim D, Banks L. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 1999;18:7690-70
3

34. Alexander A.K. Disease Burden and Health Consequences of HPV Infection.Public Health Impact of HPV Vaccines.2007 35. Boyer SN, Wazer DE, Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitinproteasome pathway. Cancer Res 1996;56:4620-24. 36. Halbert, C. L., G. W. Demers, and D. A. Galloway. 1991. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J. Virol. 65:473478. 37. Syrjanen, S. M., and K. J. Syrjanen. 1999. New concepts on the role of human papillomavirus in cell cycle regulation. Ann. Med. 31:175187. 38. Smith JS, Melendy A, Rana RK, Pimenta JM. Age-specific prevalence of infection with human papillomavirus in females: a global review. J Adolesc Health 2008;43(4 Suppl):S5- 25, S25.e21-41. 39. Trottier H, Ferreira S, Thomann P, et al. Human papillomavirus infection and reinfection in adult women: the role of sexual activity and natural immunity. Cancer Res 2010;70:8569-77. 40. Gonzalez P, Hildesheim A, Rodriguez AC,et al. Behavioral/lifestyle and immunologic factors associated with HPV infection among women older than 45 years. Cancer Epidemiol Biomarkers Prev 2010;19:3044-54. 41. Syrjanen K, Shabalova I, Petrovichev N, et al. Smoking is an independent risk factor for oncogenic human papillomavirus (HPV) infections but not for high-grade CIN. Eur J Epidemiol 2007;22:723-35. 42. Jonathan, Berek S. Berek & Novak Gynecology, 14 edition, Copyright : 2007. Lipincott Wiliams & Wilkins. 43. Vaccarella S, Herrero R, Snijders PJ, et al. Smoking and human papillomavirus infection:pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol 2008;37:536-46 44. WHO Collaborative Study of Neoplasia and Steroid Contraceptives. International Journal of Cancer 55, 228.1993. 45. E. Adam, Z. Berkova, Z. Daxnerova, J. Icenogle, W.C. Reeves and R.H. Kaufman. American Journal of Obstetrics and Gynecology 182, 257 (2000). 46. Hernandez BY, McDuffie K, Wilkens LR,Kamemoto L, Goodman MT. Diet and premalignant lesions of the cervix: evidence of a protective role for folate, riboflavin, thiamin, and vitamin B12. Cancer Causes Control 2003; 14:859-70.
4

47. Lehtinen M, Ault KA, Lyytikainen E, et al.Chlamydia trachomatis infection and risk of cervical intraepithelial neoplasia. Sex Transm Infect 2011;87:372-6 48. Silins I, Ryd W, Strand A, et al. Chlamydia trachomatis infection and persistence of human papillomavirus. Int J Cancer 2005;116:110-5. 49. Holowaty, P., A. B. Miller, T. Rohan, and T. To. 1999. Natural dysplasia of the uterine cervix. J. Natl. Cancer Inst. 91:252258. 50. Kurman, R. J., D. E. Henson, A. L. Herbst, K. L. Noeller, and M. H. Schiffman. 1994. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Workshop. JAMA 271:18661869. 51. Wright, T. C., L. Denny, L. Kuhn, A. Pollack, and A. Lorincz. 2000. HPV DNA Testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 283:8186. 52. Andrijono. MANFAAT KLINIK PEMERIKSAAN GENOTYPING HPV.FKUI.2012 53. Maleknejad, P., Rakhshan, M., Kazemi, B., Farokh, F. and Shahsavan, S. (2006a). Detection of human papillomavirus types 16 and 18 in pathologic samples from pationts with cervical cancer by PCR and RFLP methods. DARU 14 (2): 78-81. 54. Liu, S. S., R. C. Leung, K. K. Chan, A. N. Cheung, and H. Y. Ngan. 2009.Evaluation of a newly developed GenoArray human papillomavirus (HPV) genotyping assay by comparison with Roche Linear Array HPV genotyping assay. J Clin Microbiol 48:756-764 55. Halfon, P., D. Benmoura, H. Khiri, G. Penaranda, B. Blanc, D. Riggio, and M. T. Sandri. 2010. Comparison of the clinical performance of carcinogenic HPV typing of the Linear Array and Papillocheck HPV-screening assay. J Clin Virol 47:38-42. 56. Mendelshon, J., P. Howley, M. Israel, Liottal. 1995. The Molecular Basis of the Cancer. Philadelphia: WB Saunders Co.